1,950 results match your criteria: "Rush Alzheimer's Disease Center.[Affiliation]"
J Gerontol B Psychol Sci Soc Sci
December 2024
Department of Psychology, Georgetown University, Washington, District of Columbia, USA.
Front Aging Neurosci
September 2024
Lipidomics and Biomarker Discovery Lab, Department of Radiology, Brain Health Imaging Institute, Weill Cornell Medicine, New York, NY, United States.
Nat Genet
November 2024
Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, KY, USA.
medRxiv
August 2024
Brain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
J Alzheimers Dis
October 2024
Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Background: Despite the need to increase engagement of underrepresented groups (URG) in Alzheimer's disease and related dementias (ADRD) studies, enrollment remains low.
Objective: Compare referral sources across racial and ethnic groups among participants enrolled in ADRC studies.
Methods: Data for this cross-sectional secondary analysis were extracted from the National Alzheimer's Coordinating Center Uniform Data Set.
Int J Womens Health
September 2024
Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
Objective: This study investigates the thromboelastography (TEG) changes in patients with unexplained recurrent spontaneous abortion (URSA) to identify effective diagnostic markers for URSA.
Methods: We retrospectively analyzed 160 URSA patients from the Gynecology Department of the First People's Hospital of Lianyungang (June 2017 - June 2020) and compared them with 190 healthy, fertile women without adverse pregnancy histories (control group). TEG parameters were assessed using logistic regression, applying stepwise selection for model optimization.
Clin Chem Lab Med
October 2024
School of Public Health and Preventive Medicine, 2541 Monash University, Melbourne, VIC, Australia.
Objectives: As thyroid disorders are common amongst the elderly, this study aims to evaluate the reference interval (RI) for thyroid stimulating hormone (TSH) in healthy adults aged 70 years and over.
Methods: A proposed RI was determined from the Australian participants of the ASPirin in Reducing Events in the Elderly (ASPREE) randomised trial. Participants had no history of cardiovascular disease, thyroid cancer, dementia, or life-threatening illnesses.
J Affect Disord
January 2025
Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
Brain Imaging Behav
December 2024
Rush Alzheimer's Disease Center, Rush University Medical Center, 1750 W Harrison Street, Suite 1000, Chicago, IL, 60612, USA.
Financial and health literacy is essential for older adults to navigate complex decision processes in late life. However, the neurobiological basis of age-related decline in financial and health literacy is poorly understood. This study aimed to characterize progression of neurodegenerative and vascular conditions over time, and to assess how these changes coincide with declining financial and health literacy in old age.
View Article and Find Full Text PDFBrain Imaging Behav
December 2024
Rush Alzheimer's Disease Center, Rush University Medical Center, 1750 W Harrison Street, Suite 1000, Chicago, IL, 60612, USA.
Older adults with greater scam susceptibility are at greater risk for mild cognitive impairment and incident Alzheimer's dementia, regardless of baseline cognition. This, combined with documented associations between scam susceptibility and beta amyloid at death suggests that scam susceptibility may be an earlier indicator of pathological aging than cognition. Little, however, is known about whether in vivo neuroimaging markers of early-stage risk for Alzheimer's dementia are also related to scam susceptibility; such knowledge will inform upon the associations of neurodegenerative processes with scam susceptibility and may help identify vulnerable individuals.
View Article and Find Full Text PDFArch Phys Med Rehabil
September 2024
Mobility Core, University of Kansas Center for Community Access, Rehabilitation Research, Education and Service, Kansas City, KS; Landon Center on Aging, University of Kansas Medical Center, Kansas City, KS; Department of Physical Therapy, Rehabilitation Science, and Athletic Training, School of Health Professions, University of Kansas Medical Center, Kansas City, KS. Electronic address:
J Gerontol A Biol Sci Med Sci
November 2024
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Background: Few studies have analyzed sensor-derived metrics of mobility abilities and total daily physical activity (TDPA). We tested whether sensor-derived mobility metrics and TDPA indices are independently associated with mobility disabilities.
Methods: This cohort study derived mobility abilities from a belt-worn sensor that recorded annual supervised gait testing.
bioRxiv
September 2024
Department of Psychiatry, University of California, Davis, Sacramento, CA, USA.
MicroRNAs are essential post-transcriptional regulators of gene expression and involved in many biological processes; however, our understanding of their genetic regulation and role in brain illnesses is limited. Here, we mapped brain microRNA expression quantitative trait loci (miR-QTLs) using genome-wide small RNA sequencing profiles from dorsolateral prefrontal cortex (dlPFC) samples of 604 older adult donors of European ancestry. miR-QTLs were identified for 224 miRNAs (48% of 470 tested miRNAs) at false discovery rate < 1%.
View Article and Find Full Text PDFAgeing Res Rev
November 2024
1Florida Alzheimer's Disease Research Center (ADRC), University of Florida, Gainesville, FL, USA; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA. Electronic address:
Neuroimaging and biofluid biomarkers provide a proxy of pathological changes for Alzheimer's disease (AD) and are useful in improving diagnosis and assessing disease progression. However, it is not clear how race/ethnicity and different prevalence of AD risks impact biomarker levels. In this narrative review, we survey studies focusing on comparing biomarker differences between non-Hispanic White American(s) (NHW), African American(s) (AA), Hispanic/Latino American(s) (HLA), and Asian American(s) with normal cognition, mild cognitive impairment, and dementia.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
December 2024
Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Introduction: Intracranial atherosclerotic disease (ICAD) of the large cerebral arteries, a leading cause of stroke worldwide, is increasingly implicated in cognitive impairment and neurodegeneration among the general population; however, the underlying pathophysiologic mechanisms in this relationship remain unknown.
Methods: In this narrative review, we aim to provide an overview of the epidemiology and pathophysiology of ICAD, the evidence that relates ICAD to neurodegeneration, putative mechanisms, and future research directions. We synthesized available evidence on PubMed up to August 2024.
Ann Clin Transl Neurol
October 2024
Department of Radiology and Imaging Sciences, Center for Computational Biology and Bioinformatics, Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, 46202, USA.
medRxiv
August 2024
Department of Family Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
Background: Studies on middle-aged or individuals with cognitive or cardiovascular impairments, have established that intensive blood pressure (BP) control reduces cognitive decline risk. However, uncertainty exists on differential effects between antihypertensive medications (AHM) classes on this risk, independent of BP-lowering efficacy, particularly in community-dwelling hypertensive older adults.
Methods: A post-hoc analysis of the ASPREE study, a randomized trial of low-dose aspirin in adults aged 70+ years (65+ if US minorities) without baseline dementia, and followed for two years post-trial.
Alzheimers Res Ther
September 2024
Centre for Brain Research, Indian Institute of Science, Bangalore, Karnataka, 560012, India.
Background: Synaptic dysfunction, characterized by synapse loss and structural alterations, emerges as a prominent correlate of cognitive decline in Alzheimer's disease (AD). Actin cytoskeleton, which serves as the structural backbone of synaptic architecture, is observed to be lost from synapses in AD. Actin cytoskeleton loss compromises synaptic integrity, affecting glutamatergic receptor levels, neurotransmission, and synaptic strength.
View Article and Find Full Text PDFSci Rep
September 2024
Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel.
Progressive gait impairment is common among aging adults. Remote phenotyping of gait during daily living has the potential to quantify gait alterations and evaluate the effects of interventions that may prevent disability in the aging population. Here, we developed ElderNet, a self-supervised learning model for gait detection from wrist-worn accelerometer data.
View Article and Find Full Text PDFJAMA Netw Open
September 2024
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.
Importance: Difficulties in identifying modifiable risk factors associated with daily physical activity may impede public health efforts to mitigate the adverse health outcomes of a sedentary lifestyle in an aging population.
Objective: To test the hypothesis that adding baseline sensor-derived mobility metrics to diverse baseline motor and nonmotor variables accounts for the unexplained variance of declining daily physical activity among older adults.
Design, Setting, And Participants: This cohort study analyzed data from participants of the Rush Memory and Aging Project (MAP), an ongoing longitudinal clinical pathological study that began to enroll older adults (age range, 59.
Alzheimers Dement
October 2024
Department of Psychology, University of Michigan, Ann Arbor, Michigan, USA.
Introduction: Loneliness has a rising public health impact, but research involving neuropathology and representative cohorts has been limited.
Methods: Inverse odds of selection weights were generalized from the autopsy sample of Rush Alzheimer's Disease Center cohorts (N = 680; 89 ± 9 years old; 25% dementia) to the US-representative Health and Retirement Study (N = 8469; 76 ± 7 years old; 5% dementia) to extend external validity. Regressions tested cross-sectional associations between loneliness and (1) Alzheimer's disease (AD) and cerebrovascular pathology; (2) five cognitive domains; and (3) relationships between pathology and cognition, adjusting for depression.
Alzheimers Dement
November 2024
Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H. Sergievsky Center, Columbia University, New York, New York, USA.
Background: Few rare variants have been identified in genetic loci from genome-wide association studies (GWAS) of Alzheimer's disease (AD), limiting understanding of mechanisms, risk assessment, and genetic counseling.
Methods: Using genome sequencing data from 197 families in the National Institute on Aging Alzheimer's Disease Family Based Study and 214 Caribbean Hispanic families, we searched for rare coding variants within known GWAS loci from the largest published study.
Results: Eighty-six rare missense or loss-of-function (LoF) variants completely segregated in 17.
Curr Dev Nutr
August 2024
USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, United States.
The hormonally active form of vitamin D, 1,25-Dihydroxyvitamin D3 [1,25(OH)D], has been associated with neuroprotective effects in the brain, but has been difficult to measure in human brain tissue because of its low concentration. The aim of this study was to develop and validate a sensitive method to quantify 1,25(OH)D in the human brain. Prior to analysis by the LC-MS/MS, the samples were derivatized with 4-phenyl-1,2,4-triazoline-3,5-dione.
View Article and Find Full Text PDFAlzheimers Dement
October 2024
Mayo Clinic Florida, Jacksonville, Florida, USA.
Introduction: Multi-omics studies in Alzheimer's disease (AD) revealed many potential disease pathways and therapeutic targets. Despite their promise of precision medicine, these studies lacked Black Americans (BA) and Latin Americans (LA), who are disproportionately affected by AD.
Methods: To bridge this gap, Accelerating Medicines Partnership in Alzheimer's Disease (AMP-AD) expanded brain multi-omics profiling to multi-ethnic donors.
Front Aging Neurosci
August 2024
Danone Specialised Nutrition, Hoofddorp, Netherlands.
Introduction: Neurobiological changes in the hippocampus are a common consequence of aging. However, there are differences in the rate of decline and overall volume loss in people with no cognitive impairment compared to those with mild cognitive impairment (MCI) and Alzheimer's disease (AD). This systematic literature review was conducted to determine the relationship between hippocampal atrophy and changes in hippocampal volume in the non-cognitively impaired brain and those with MCI or AD.
View Article and Find Full Text PDF